Company Filing History:
Years Active: 2012-2018
Title: Ramanuj Dasgupta: Innovator in Chemical Screening Technologies
Introduction
Ramanuj Dasgupta is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of chemical screening technologies, holding a total of 4 patents. His work focuses on developing innovative methods that can lead to advancements in medical treatments.
Latest Patents
One of his latest patents is a targeted chemical high-throughput screening method. This novel method integrates a 'sensitized' chemical genetic high-throughput screen (HTS) with RNA interference (RNAi) screening technology. The method has been utilized to identify specific small molecule inhibitors and activators of the Wnt pathway. More specifically, it aims to identify small molecule inhibitors and activators that target the activity of a stabilized pool of β-catenin. The compounds identified through this method have shown potential as small molecule inhibitors of the Wnt pathway, which may be prepared as pharmaceutical compositions for the prevention and treatment of various conditions, including cancer.
Another significant patent involves oxazole and thiazole compounds as β-catenin modulators. This patent describes a series of compounds that act as small molecule inhibitors of the Wnt pathway, specifically targeting the activity of the stabilized pool of β-catenin. These compounds can also be formulated into pharmaceutical compositions for treating a range of conditions in mammals, including humans.
Career Highlights
Ramanuj Dasgupta is affiliated with New York University, where he continues to advance his research and innovation in the field of chemical screening. His work has garnered attention for its potential applications in medical science and drug development.
Collaborations
He collaborates with notable colleagues, including Foster Casimir Gonsalves and Susan Katherine Logan, who contribute to his research endeavors.
Conclusion
Ramanuj Dasgupta's innovative work in chemical screening technologies positions him as a key figure in the development of new therapeutic strategies. His patents reflect a commitment to advancing medical science and improving treatment options for various conditions.